Wil industry's concerns over EU human tissue text mean delays?
This article was originally published in Clinica
Executive Summary
The European Commission unit responsible for writing the first EU-wide requirements for human tissue engineered products (HTEPs) is keen to issue its first draft Regulation within the next few months. But industry is critical of many of the fundamental approaches proposed in the Commission's recently issued consultation paper. Amanda Maxwell spoke to Shayesteh Furst-Ladani, EuropaBio human tissue expert, and also invited comments from Phil Brown of Quintiles Consulting, to learn what the concerns are and to gauge the likelihood of swift progress that is needed to halt the proliferation of national rules in this field
You may also be interested in...
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.